Trials / Conditions / Cardiac Repolarization
Cardiac Repolarization
6 registered clinical trials studyying Cardiac Repolarization — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult NCT07272629 | Sanofi | Phase 1 |
| Terminated | A Study of Milademetan Administration on Cardiac Repolarization in Healthy Subjects NCT05758818 | Rain Oncology Inc | Phase 1 |
| Completed | Phase 1 Study to Assess the Effects of EVP-6124 on the QT/QTc Interval in Healthy Subjects NCT01487135 | FORUM Pharmaceuticals Inc | Phase 1 |
| Completed | Droperidol and Cardiac Repolarization NCT01819857 | Medical University of Gdansk | Phase 4 |
| Completed | A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy Subjects NCT01232413 | Astellas Pharma Inc | Phase 1 |
| Completed | Effect of Beta-blocker Therapy on QTc Response in Exercise and Recovery in Normal Subjects NCT00588965 | MetroHealth Medical Center | N/A |